[HTML][HTML] PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy

S Fattahi, Z Khalifehzadeh-Esfahani… - Immunologic …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a β …

[PDF][PDF] PI3K/Akt/mTOR pathway: a potential target for anti‑SARS‑CoV‑2 therapy

S Fattahi, Z Khalifehzadeh‑Esfahani… - researchgate.net
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a β …

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy

S Fattahi, Z Khalifehzadeh-Esfahani… - Immunologic …, 2022 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a β …

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy

S Fattahi, Z Khalifehzadeh-Esfahani… - IMMUNOLOGIC …, 2022 - eprints.mui.ac.ir
Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a beta …

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy

S Fattahi, Z Khalifehzadeh-Esfahani… - Immunologic …, 2022 - search.proquest.com
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a β …

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy.

S Fattahi, Z Khalifehzadeh-Esfahani… - 2022 - cabidigitallibrary.org
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a β …

[HTML][HTML] PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy

S Fattahi, Z Khalifehzadeh-Esfahani… - Immunologic …, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a β …

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy.

S Fattahi, Z Khalifehzadeh-Esfahani… - Immunologic …, 2022 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a β …

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy

S Fattahi, Z Khalifehzadeh-Esfahani… - IMMUNOLOGIC …, 2022 - eprints.mui.ac.ir
Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a beta …

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy.

S Fattahi, Z Khalifehzadeh-Esfahani… - Immunologic …, 2022 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a β …